These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 23691974)

  • 21. Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages.
    Sierra JR; Corso S; Caione L; Cepero V; Conrotto P; Cignetti A; Piacibello W; Kumanogoh A; Kikutani H; Comoglio PM; Tamagnone L; Giordano S
    J Exp Med; 2008 Jul; 205(7):1673-85. PubMed ID: 18559453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel antitumor prodrug platform designed to be cleaved by the endoprotease legumain.
    Stern L; Perry R; Ofek P; Many A; Shabat D; Satchi-Fainaro R
    Bioconjug Chem; 2009 Mar; 20(3):500-10. PubMed ID: 19196156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation into the role of tumor-associated macrophages in the antitumor activity of Doxil.
    Banciu M; Schiffelers RM; Storm G
    Pharm Res; 2008 Aug; 25(8):1948-55. PubMed ID: 18523874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COX-2 silencing enhances tamoxifen antitumor activity in breast cancer in vivo and in vitro.
    Du Y; Shi A; Han B; Li S; Wu D; Jia H; Zheng C; Ren L; Fan Z
    Int J Oncol; 2014 Apr; 44(4):1385-93. PubMed ID: 24535190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Target validation using RNA interference in solid tumors.
    Aharinejad S; Sioud M; Lucas T; Abraham D
    Methods Mol Biol; 2007; 361():227-38. PubMed ID: 17172715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fes tyrosine kinase expression in the tumor niche correlates with enhanced tumor growth, angiogenesis, circulating tumor cells, metastasis, and infiltrating macrophages.
    Zhang S; Chitu V; Stanley ER; Elliott BE; Greer PA
    Cancer Res; 2011 Feb; 71(4):1465-73. PubMed ID: 21159660
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CPI-0004Na, a new extracellularly tumor-activated prodrug of doxorubicin: in vivo toxicity, activity, and tissue distribution confirm tumor cell selectivity.
    Dubois V; Dasnois L; Lebtahi K; Collot F; Heylen N; Havaux N; Fernandez AM; Lobl TJ; Oliyai C; Nieder M; Shochat D; Yarranton GT; Trouet A
    Cancer Res; 2002 Apr; 62(8):2327-31. PubMed ID: 11956091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting prion-like protein doppel selectively suppresses tumor angiogenesis.
    Al-Hilal TA; Chung SW; Choi JU; Alam F; Park J; Kim SW; Kim SY; Ahsan F; Kim IS; Byun Y
    J Clin Invest; 2016 Apr; 126(4):1251-66. PubMed ID: 26950422
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy.
    Priceman SJ; Sung JL; Shaposhnik Z; Burton JB; Torres-Collado AX; Moughon DL; Johnson M; Lusis AJ; Cohen DA; Iruela-Arispe ML; Wu L
    Blood; 2010 Feb; 115(7):1461-71. PubMed ID: 20008303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sox17 promotes tumor angiogenesis and destabilizes tumor vessels in mice.
    Yang H; Lee S; Lee S; Kim K; Yang Y; Kim JH; Adams RH; Wells JM; Morrison SJ; Koh GY; Kim I
    J Clin Invest; 2013 Jan; 123(1):418-31. PubMed ID: 23241958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
    Joshi S; Singh AR; Zulcic M; Durden DL
    Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.
    Murphy EA; Majeti BK; Barnes LA; Makale M; Weis SM; Lutu-Fuga K; Wrasidlo W; Cheresh DA
    Proc Natl Acad Sci U S A; 2008 Jul; 105(27):9343-8. PubMed ID: 18607000
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Legumain correlates with neuroblastoma differentiation and can be used in prodrug design.
    Zhang M; Jiang Z; Chen S; Wu Z; Chen K; Wu Y
    Chem Biol Drug Des; 2018 Feb; 91(2):534-544. PubMed ID: 28994241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual targeting of tumor angiogenesis and chemotherapy by endostatin-cytosine deaminase-uracil phosphoribosyltransferase.
    Chen CT; Yamaguchi H; Lee HJ; Du Y; Lee HH; Xia W; Yu WH; Hsu JL; Yen CJ; Sun HL; Wang Y; Yeh ET; Hortobagyi GN; Hung MC
    Mol Cancer Ther; 2011 Aug; 10(8):1327-36. PubMed ID: 21610170
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino-biphosphonate-mediated MMP-9 inhibition breaks the tumor-bone marrow axis responsible for myeloid-derived suppressor cell expansion and macrophage infiltration in tumor stroma.
    Melani C; Sangaletti S; Barazzetta FM; Werb Z; Colombo MP
    Cancer Res; 2007 Dec; 67(23):11438-46. PubMed ID: 18056472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tailor-made legumain/pH dual-responsive doxorubicin prodrug-embedded nanoparticles for efficient anticancer drug delivery and in situ monitoring of drug release.
    Li Y; Niu Y; Zhu J; Gao C; Xu Q; He Z; Chen D; Xu M; Liu Y
    Nanoscale; 2020 Jan; 12(4):2673-2685. PubMed ID: 31942900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prodrug-embedded angiogenic vessel-targeting nanoparticle: A positive feedback amplifier in hypoxia-induced chemo-photo therapy.
    Guo D; Xu S; Wang N; Jiang H; Huang Y; Jin X; Xue B; Zhang C; Zhu X
    Biomaterials; 2017 Nov; 144():188-198. PubMed ID: 28837960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinases.
    Atkinson JM; Falconer RA; Edwards DR; Pennington CJ; Siller CS; Shnyder SD; Bibby MC; Patterson LH; Loadman PM; Gill JH
    Cancer Res; 2010 Sep; 70(17):6902-12. PubMed ID: 20663911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SHIP represses lung inflammation and inhibits mammary tumor metastasis in BALB/c mice.
    Hamilton MJ; Halvorsen EC; LePard NE; Bosiljcic M; Ho VW; Lam V; Banáth J; Bennewith KL; Krystal G
    Oncotarget; 2016 Jan; 7(4):3677-91. PubMed ID: 26683227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
    Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
    Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.